OPKO Health Reports 2017 Third Quarter Highlights and Financial Results

RAYALDEE total prescriptions increased 66% in Q3 2017 compared with Q2 20174Kscore utilization increased ...

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results

RAYALDEE total prescriptions increased 66% in Q3 2017 compared with Q2 20174Kscore utilization increased ...

Proteon Therapeutics Announces Third Quarter 2017 Financial Results

WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company ...

Proteon Therapeutics Announces Third Quarter 2017 Financial Results

WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company ...

Hypophosphatemia Data From AMAG Phase 3 Trial Presented at the American Society of Nephrology

Data Shows Patients Treated with Feraheme® (ferumoxytol) were Less Likely to Develop Severe Hypophosphatemia ...

[sam_pro id=0_12 codes="true"]